CIK 0001158895 · Large accelerated filer
LEMAITRE VASCULAR INC
Sign in to watch- Ticker
- LMAT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- operating
- Phone
- 781-221-2266
- Business address
- 63 SECOND AVENUE, BURLINGTON, MA, 01803
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-01 | Roberts David B President and Director | Grant or award · Dividend Equivalent Rights | +1.77 | 29.25 | ||
| 2023-09-01 | Roberts David B President and Director | Grant or award · Dividend Equivalent Rights | +2.49 | 27.18 | ||
| 2023-09-01 | Roberts David B President and Director | Grant or award · Dividend Equivalent Rights | +4.75 | 37.28 | ||
| 2023-09-01 | Roberts David B President and Director | Grant or award · Dividend Equivalent Rights | +6.45 | 19.65 | ||
| 2023-09-01 | LeMaitre George W Chairman and CEO | Grant or award · Dividend Equivalent Rights | +3.92 | 83.36 | ||
| 2023-09-01 | LeMaitre George W Chairman and CEO | Grant or award · Dividend Equivalent Rights | +5.14 | 82.94 | ||
| 2023-09-01 | LeMaitre George W Chairman and CEO | Grant or award · Dividend Equivalent Rights | +10.44 | 78.8 | ||
| 2023-09-01 | LeMaitre George W Chairman and CEO | Grant or award · Dividend Equivalent Rights | +14.18 | 43.24 | ||
| 2023-09-01 | LeMaitre George W Chairman and CEO | Grant or award · Dividend Equivalent Rights | +7.24 | 79.44 | ||
| 2023-08-23 | LeMaitre George W Chairman and CEO | Gift | −625 | 2,344,685 | ||
| 2023-06-02 | Ross Bridget A Director | Option exercise | +5,000 | $37.29 | $186K | 6,169 |
| 2023-06-02 | Ross Bridget A Director | Sale | −5,000 | $64.24 | $321K | 1,169 |
| 2023-06-02 | Ross Bridget A Director | Option exercise · Stock Option (Right to Buy) | −5,000 | 0 | ||
| 2023-06-01 | Jasinski Lawrence J Director | Grant or award · Dividend Equivalent Rights | +0.85 | 6.46 | ||
| 2023-06-01 | Jasinski Lawrence J Director | Grant or award · Dividend Equivalent Rights | +1.3 | 2.96 | ||
| 2023-06-01 | O'Connor John James Director | Grant or award · Dividend Equivalent Rights | +0.85 | 6.46 | ||
| 2023-06-01 | O'Connor John James Director | Grant or award · Dividend Equivalent Rights | +1.3 | 2.96 | ||
| 2023-06-01 | Ross Bridget A Director | Grant or award · Dividend Equivalent Rights | +0.85 | 6.46 | ||
| 2023-06-01 | Ross Bridget A Director | Grant or award · Dividend Equivalent Rights | +1.3 | 2.96 | ||
| 2023-06-01 | Roush John A Director | Grant or award · Dividend Equivalent Rights | +0.85 | 6.46 |
Page 65 of 66 · 1,303 trades